Evidence map›Paper›PMID 37722058›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing.

Zheng Liu, Wenjie Liu, Wei Wang, Yibao Ma, Yufeng Wang, David L Drum, Jinyang Cai, Hallie Blevins, Eun Lee, Syed Shah and 5 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 86 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Oxidative Phosphorylation and Fatty Acid Oxidation Are Central to Mitochondrial Metabolism Rewiring in CML Stem/Progenitor Cell Survival.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Zheng LiuDepartment of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.ORCID 0000-0002-7260-209X
Wenjie LiuDepartment of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
Wei WangDepartment of Biochemistry, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
Yibao MaDepartment of Biochemistry, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
Yufeng WangDivision of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
David L DrumDivision of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.ORCID 0009-0005-0845-4167
Jinyang CaiDepartment of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.ORCID 0000-0002-7385-8281
Hallie BlevinsDepartment of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
Eun LeeMassey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
Syed ShahMassey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.ORCID 0009-0003-4083-0535
Paul B FisherDepartment of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.ORCID 0000-0002-0085-4546
Xinhui WangDivision of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
Xianjun FangDepartment of Biochemistry, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.
Chunqing GuoDepartment of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.ORCID 0000-0002-3148-8542
Xiang-Yang WangDepartment of Human & Molecular Genetics, Virginia Commonwealth University School of Medicine, Richmond, VA 23298.ORCID 0000-0003-2421-5367
Virginia Commonwealth University · USHarvard University · US

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Renato Martins · 1985 to 2026
$51.0M
A novel role of IGFBP7 in the microenvironment of hepatocellular carcinomaR01CA240004 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SARKAR, DEVANAND, WANG, XIANG-YANG SHAWN · 2019 to 2023
$2.4M
Interplay between tumor and microenvironment in bone metastasisR01CA259599 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI FISHER, PAUL B, WANG, XIANG-YANG SHAWN · 2021 to 2025
$2.3M
Metabolic reprograming of fatty acid beta-oxidation to improve cancer immunotherapyR01CA229812 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI FANG, XIANJUN, WANG, XIANG-YANG SHAWN · 2019 to 2023
$2.0M
Prevention of post-therapy breast cancer metastasisR01CA226981 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WANG, XINHUI · 2019 to 2023
$1.8M
Host-tumor interactions and cancer relapse after radiation therapyR01CA175033 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI WANG, XIANG-YANG SHAWN · 2014 to 2018
$1.6M
NCI NIH HHS P30 CA016059NCI NIH HHS R01 CA175033NCI NIH HHS R01 CA226981NCI NIH HHS R01 CA229812NCI NIH HHS R01 CA240004NCI NIH HHS R01 CA259599
6 · The paper itself

Abstract

Although tumor-intrinsic fatty acid β-oxidation (FAO) is implicated in multiple aspects of tumorigenesis and progression, the impact of this metabolic pathway on cancer cell susceptibility to immunotherapy remains unknown. Here, we report that cytotoxicity of killer T cells induces activation of FAO and upregulation of carnitine palmitoyltransferase 1A (CPT1A), the rate-limiting enzyme of FAO in cancer cells. The repression of CPT1A activity or expression renders cancer cells more susceptible to destruction by cytotoxic T lymphocytes. Our mechanistic studies reveal that FAO deficiency abrogates the prosurvival signaling in cancer cells under immune cytolytic stress. Furthermore, we identify T cell-derived IFN-γ as a major factor responsible for induction of CPT1A and FAO in an AMPK-dependent manner, indicating a dynamic interplay between immune effector cells and tumor targets. While cancer growth in the absence of CPT1A remains largely unaffected, established tumors upon FAO inhibition become significantly more responsive to cellular immunotherapies including chimeric antigen receptor-engineered human T cells. Together, these findings uncover a mode of cancer resistance and immune editing that can facilitate immune escape and limit the benefits of immunotherapies.

Indexed as

Carnitine O-PalmitoyltransferaseNeoplasmsCytotoxicity, ImmunologicFatty AcidsHumansLipid MetabolismT-Lymphocytes, CytotoxicCarnitine O-PalmitoyltransferaseCPT1A protein, humanFatty Acidscancer metabolismcarnitine palmitoyltransferase 1Acellular immunotherapyfatty acid oxidationtherapeutic resistance

Identifiers

PMID37722058
PMCPMC10523454
OpenAlexW4386824165

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.